文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.

作者信息

Schölvinck Dirk, Künzli Hannah, Meijer Sybren, Seldenrijk Kees, van Berge Henegouwen Mark, Bergman Jacques, Weusten Bas

机构信息

Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, Nieuwegein, The Netherlands.

Department of Gastroenterology and Hepatology, Academic Medical Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

出版信息

Surg Endosc. 2016 Sep;30(9):4102-13. doi: 10.1007/s00464-016-5071-y. Epub 2016 Jun 29.


DOI:10.1007/s00464-016-5071-y
PMID:27357927
Abstract

BACKGROUND: Esophagectomy for submucosal (T1b) esophageal adenocarcinoma (EAC) is performed in order to optimize patient outcomes given the risk of concurrent lymph node metastases (LNM). However, not seldom, comorbidity precludes these patients from surgery. Therefore, the aim of our study was to assess the course of follow-up after treatment in submucosal EAC patients undergoing surgery versus conservative therapy and to evaluate the incidence of metastatic disease. METHODS: Between 2001 and 2012, all patients undergoing diagnostic endoscopic resection for EAC in two centers were reviewed. Only patients with histopathologically proven submucosal tumor invasion were included. Submucosal EACs were divided into tumors that were removed radically (R0) and irradically (R1). Subsequently, in the R0 group, EACs were classified as either low risk (LR; submucosal invasion <500 nm, G1-G2, no LVI) or high risk (HR; deep submucosal invasion >500 nm, G3-G4 and/or LVI). Metastatic disease was defined as LNM in surgical resection specimen and/or evidence of malignant disease during follow-up (FU). RESULTS: Sixty-nine patients with a submucosal EAC were included [23 R1-resections and 46 R0-resection (14 R0-LR and 32 R0-HR)]. Twenty-six patients underwent surgical treatment (1 R0-LR, 12 R0-HR and 13 R1). None of the 14 R0-LR patients developed metastatic disease after a median FU of 60 months. In the R0-HR group and R1 group, metastatic disease was diagnosed in 16 and 30 % of patients, respectively. Surgical patients tended to have a better overall survival than non-surgical patients (p = 0.09). Tumor-related deaths, however, were 12 % in both groups. CONCLUSIONS: In LR submucosal EAC, the risk of metastatic disease appears to be very low. In deep submucosal EAC (either R0- or R1-resection), the rate of metastatic disease is lower than reported in earlier surgical series. Given the reasonable disease-free survival and high background mortality, conservative management of these patients seems to be a valid alternative for surgery in selected cases.

摘要

相似文献

[1]
Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.

Surg Endosc. 2016-9

[2]
Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience.

World J Gastroenterol. 2018-11-7

[3]
Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.

Ann Surg Oncol. 2017-11-16

[4]
Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.

Dis Esophagus. 2017-2-1

[5]
Endoscopic submucosal dissection for early esophageal adenocarcinoma: low rates of metastases in mucosal cancers with poor differentiation.

Gastrointest Endosc. 2024-10

[6]
Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.

J Gastrointest Surg. 2016-1

[7]
Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.

Ann Surg. 2008-3

[8]
Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma.

United European Gastroenterol J. 2018-6

[9]
Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.

World J Gastroenterol. 2013-3-7

[10]
The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns.

Surg Endosc. 2015-7

引用本文的文献

[1]
Reassessment reveals underestimation of infiltration depth in surgical resection specimens with lymph-node positive T1b esophageal adenocarcinoma.

Endosc Int Open. 2025-2-5

[2]
Outcomes after radical endoscopic resection of high risk T1 esophageal adenocarcinoma: an international multicenter retrospective cohort study.

Endoscopy. 2025-4-28

[3]
Reasons for fear of cancer recurrence after endoscopic treatment of T1 esophageal adenocarcinoma. A semi-structured interview study.

Dis Esophagus. 2024-11-28

[4]
Special requirements for TNM-staging in esophageal cancer.

J Thorac Dis. 2024-6-30

[5]
Latest Advances in Endoscopic Detection of Oesophageal and Gastric Neoplasia.

Diagnostics (Basel). 2024-1-30

[6]
History and evidence for state of the art of lymphadenectomy in esophageal cancer surgery.

Dis Esophagus. 2024-4-2

[7]
Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review.

Cancers (Basel). 2023-5-3

[8]
Feasibility and Safety of Tailored Lymphadenectomy Using Sentinel Node-Navigated Surgery in Patients with High-Risk T1 Esophageal Adenocarcinoma.

Ann Surg Oncol. 2023-7

[9]
A population-based investigation: How to identify high-risk T1-2N0 esophageal cancer patients?

Front Surg. 2023-1-17

[10]
The 8th Wonder of the Cancer World: Esophageal Cancer and Inflammation.

Diseases. 2022-7-7

本文引用的文献

[1]
Submucosal invasion and risk of lymph node invasion in early Barrett's cancer: potential impact of different classification systems on patient management.

United European Gastroenterol J. 2015-12

[2]
Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.

J Gastrointest Surg. 2016-1

[3]
Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.

Ann Thorac Surg. 2015-6

[4]
Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).

Gut. 2015-3-2

[5]
The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns.

Surg Endosc. 2015-7

[6]
Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus.

Gastroenterology. 2013-11-20

[7]
Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study.

Gastroenterology. 2013-3-28

[8]
Trends in esophageal adenocarcinoma incidence and mortality.

Cancer. 2012-12-11

[9]
Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus.

Cochrane Database Syst Rev. 2012-11-14

[10]
Quality of life after an esophagectomy.

Surg Clin North Am. 2012-8-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索